Notably, a 2024 study demonstrated that TMPO-AS1 sponges miR-383-5p to upregulate LDHA in TNBC, reinforcing its role as a ceRNA in aggressive BC subtypes (Vats et al., 2024). This evidence concerns the gene TMPO and breast cancer.